vorinostat has been researched along with Carcinoma, Ductal, Breast in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Carcinoma, Ductal, Breast: An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Short-term vorinostat administration is associated with a significant decrease in expression of proliferation-associated genes in untreated breast cancers." | 9.17 | Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer. ( Briest, S; Chao, C; Cheng, Z; Davidson, NE; Espinoza-Delgado, I; Fackler, M; Gabrielson, E; Higgins, M; Jacobs, LK; Jeter, SC; Lange, J; Powers, P; Rudek, MA; Slater, SA; Stearns, V; Sugar, E; Sukumar, S; Tsangaris, TN; Yoshizawa, C, 2013) |
| "Short-term vorinostat administration is associated with a significant decrease in expression of proliferation-associated genes in untreated breast cancers." | 5.17 | Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer. ( Briest, S; Chao, C; Cheng, Z; Davidson, NE; Espinoza-Delgado, I; Fackler, M; Gabrielson, E; Higgins, M; Jacobs, LK; Jeter, SC; Lange, J; Powers, P; Rudek, MA; Slater, SA; Stearns, V; Sugar, E; Sukumar, S; Tsangaris, TN; Yoshizawa, C, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stearns, V | 1 |
| Jacobs, LK | 1 |
| Fackler, M | 1 |
| Tsangaris, TN | 1 |
| Rudek, MA | 1 |
| Higgins, M | 1 |
| Lange, J | 1 |
| Cheng, Z | 1 |
| Slater, SA | 1 |
| Jeter, SC | 1 |
| Powers, P | 1 |
| Briest, S | 1 |
| Chao, C | 1 |
| Yoshizawa, C | 1 |
| Sugar, E | 1 |
| Espinoza-Delgado, I | 1 |
| Sukumar, S | 1 |
| Gabrielson, E | 1 |
| Davidson, NE | 1 |
1 trial available for vorinostat and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Aurora Kinase A; Breast Neoplasms; Carcinoma, Ductal, Breast; Ce | 2013 |